A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Clinical trial NCT02256150 · COMPLETED
Trial details
- NCT number
- NCT02256150
- Sponsor
- Asahi Kasei Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2019-03-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.